НовостиBenzingaRBC Capital Maintains Sector Perform on aTyr Pharma, Lowers Price Target to $6 RBC Capital Maintains Sector Perform on aTyr Pharma, Lowers Price Target to $6 Benzinga 2026.11.06 19:26 (GMT+0) Открыть на Benzinga Другие новости